METTL3 is frequently upregulated in hepatocellular carcinoma patients, and the upregulated METTL3 inhibits the expression of tumor suppressor SOCS2 through m6A methylation and promotes the development of hepatocellular carcinoma.327. This evidence concerns the gene SOCS2 and hepatocellular carcinoma.